InvestorsHub Logo
Followers 105
Posts 2892
Boards Moderated 0
Alias Born 09/16/2011

Re: None

Friday, 09/12/2014 7:05:06 PM

Friday, September 12, 2014 7:05:06 PM

Post# of 263759
•••>Ordinarily CNBC does not grant on-air interviews to OTC companies. But there have been exceptions. One such exception, a while back, was an energy supplement company endorsed by Tiger Woods.

I believe that just as they made an exception for the OTC supplement company because they believed that the Tiger Woods endorsement made it an interesting interview for their viewers, I could see the possibility of them being interested in interviewing Robert Calkin on-air. Keep in mind that CNBC has been airing a number of mj related specials over and over again. If they didn't believe that this topic was of interest to their viewers, they would quit airing them. Below I've listed some of the specials that CNBC has aired recently:

-Marijuana in America: Colorado Pot Rush
-Business of Marijuana: The Business
-Marijuana Inc: Inside America's Pot Industry

If Robert Calkin could land an on-air interview with CNBC, I honestly believe that Green Cures stock (GRCU) would absolutely explode to the upside. Since Mr. Calkin is a long time industry expert and navigator of cannabis/mj regulations, he would surely be of interest to that network. I would think that Bob would want to get all of his ducks in a row first, such as buttoning up the e-commerce websites and procuring enough product to meet the anticipated demand. But once that is done, I could see him reaching out to a network like CNBC to communicate the existence of this enterprise to the general investing public.

As always, simply my opinion.

GRCU